Template:Percutaneous Coronary Intervention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(26 intermediate revisions by 4 users not shown) | |||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
'''Percutaneous Coronary Intervention Microchapters | '''Percutaneous Coronary Intervention Guidelines Microchapters | ||
''' | ''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
Line 10: | Line 10: | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
[[Percutaneous | [[Percutaneous coronary intervention: basic principles and guidelines|Home]] | ||
|- | |- | ||
! | ! | ||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Angioplasty (patient information)|Patient | [[Angioplasty (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |||
! | |||
[[Percutaneous coronary intervention overview|Overview]] | |||
|- | |||
! | |||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! | ||
PCI Approaches: | |||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
|- bgcolor=" | |||
! | ! | ||
CAD Revascularization: | CAD Revascularization: | ||
Line 34: | Line 38: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
::[[Percutaneous | ::[[Percutaneous coronary intervention heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]] | ||
|- | |- | ||
! | ! | ||
:[[Percutaneous Coronary | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention left main coronary artery disease|Left Main Coronary Artery Disease]] | |||
|- | |||
! | |||
:[[ | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Intervention in left main coronary artery disease]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention revascularization to improve symptoms|Revascularization to Improve Symptoms]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention hybrid coronary revascularization|Hybrid Coronary Revascularization]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Pre-procedural Considerations: | Pre-procedural Considerations: | ||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention anaphylactoid reactions|Anaphylactoid Reactions]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention statin treatment|Statin Treatment]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention bleeding risk|Bleeding Risk]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
::[[Percutaneous coronary intervention role of onsite surgical backup|Role of Onsite Surgical Backup]] | |||
::[[Percutaneous | |||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Procedural Considerations: | Procedural Considerations: | ||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention vascular access|Vascular Access]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:PCI in Specific Clinical Situations: | :PCI in Specific Clinical Situations: | ||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention asymptomatic ischemia or CCS class I or II angina|Asymptomatic Ischemia or CCS Class I or II Angina]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention CCS class III angina|CCS Class III Angina]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention unstable Angina/non-ST-elevation myocardial infarction|Unstable Angina/Non–ST-Elevation Myocardial Infarction]] | |||
|- | |||
! | |||
:: | |- bgcolor="PaleTurquoise" | ||
! | |||
::ST-Elevation Myocardial Infarction: | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention general and specific considerations|General and Specific Considerations]] | |||
|- | |||
! | |||
:::[[Percutaneous Coronary | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention coronary angiography strategies in STEMI|Coronary Angiography Strategies in STEMI]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention primary PCI of the infarct artery|Primary PCI of the Infarct Artery]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention delayed or elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention fibrinolytic-ineligible patients|Fibrinolytic-Ineligible Patients]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention facilitated PCI|Facilitated PCI]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention rescue PCI (PCI after failed fibrinolysis)|Rescue PCI]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:::[[Percutaneous coronary intervention after successful fibrinolysis or for patients not undergoing primary reperfusion|After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention Cardiogenic shock|Cardiogenic Shock]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention prior coronary bypass surgery|Prior Coronary Bypass Surgery]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention revascularization before non-cardiac surgery|Revascularization Before Non-cardiac Surgery]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:Adjunctive Diagnostic Devices: | :Adjunctive Diagnostic Devices: | ||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention fractional flow reserve|Fractional Flow Reserve]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention intravascular ultrasound|Intravascular Ultrasound]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:Adjunctive Therapeutic Devices: | :Adjunctive Therapeutic Devices: | ||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention coronary atherectomy|Coronary Atherectomy]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention thrombectomy|Thrombectomy]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention laser angioplasty|Laser Angioplasty]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention cutting balloon angioplasty|Cutting Balloon Angioplasty]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
::[[Percutaneous coronary intervention embolic protection devices|Embolic Protection Devices]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Percutaneous coronary intervention percutaneous hemodynamic support devices|Percutaneous Hemodynamic Support Devices]] | |||
|- | |||
! | |||
: | |- bgcolor="PaleTurquoise" | ||
! | |||
:Antiplatelet therapy: | |||
|- | |||
! | |||
:Antiplatelet Therapy | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention oral antiplatelet therapy|Oral Antiplatelet Therapy]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists|Glycoprotein IIb/IIIa Receptor Antagonists]] | |||
|- | |||
! | |||
::Intravenous Antiplatelet | |- bgcolor="PaleTurquoise" | ||
! | |||
::Intravenous Antiplatelet therapy: | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::::[[Percutaneous coronary intervention ST-elevation myocardial infarction (STEMI)|STEMI]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::::[[Percutaneous coronary intervention unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)|UA/NSTEMI]] | |||
|- | |||
! | |||
:::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::::[[Percutaneous coronary intervention sudden ischemia heart disease (SIHD)|SIHD]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:Anticoagulant Therapy: | :Anticoagulant Therapy: | ||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention use of parenteral anticoagulants during PCI|Parenteral Anticoagulants During PCI]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention unfractionated heparin|Unfractionated Heparin]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention enoxaparin|Enoxaparin]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention bivalirudin and argatoban|Bivalirudin and Argatroban]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention fondaparinux|Fondaparinux]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention no-reflow pharmacological therapies|No-Reflow Pharmacological Therapies]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:PCI in Specific Anatomic Situations: | :PCI in Specific Anatomic Situations: | ||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention chronic total occlusions|Chronic Total Occlusions]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention saphenous vein grafts|Saphenous Vein Grafts]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention bifurcation lesions|Bifurcation Lesions]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention aorto-ostial stenoses|Aorto-Ostial Stenoses]] | |||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention calcified lesions|Calcified Lesions]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:PCI in Specific Patient Populations: | :PCI in Specific Patient Populations: | ||
|- | |||
! | |||
::[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
::[[Percutaneous coronary intervention chronic kidney disease|Chronic Kidney Disease]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention peri-procedural myocardial infarction assessment|Peri-procedural Myocardial Infarction Assessment]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
|- | ! | ||
! | :[[Percutaneous coronary intervention vascular closure devices|Vascular Closure Devices]] | ||
|- | |||
! | |||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Post-Procedural Considerations: | Post-Procedural Considerations: | ||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention post-procedural antiplatelet therapy|Post-procedural Antiplatelet Therapy]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Percutaneous coronary intervention proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Percutaneous coronary intervention clopidogrel genetic testing|Clopidogrel Genetic Testing]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Percutaneous coronary intervention platelet function testing|Platelet Function Testing]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention restenosis|Restenosis]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Percutaneous coronary intervention exercise testing|Exercise Testing]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
|- | ! | ||
! | :[[Percutaneous coronary intervention cardiac rehabilitation|Cardiac Rehabilitation]] | ||
|- | |||
! | |||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Quality and Performance Considerations: | Quality and Performance Considerations: | ||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention quality and performance|Quality and Performance]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
! | |||
:[[Percutaneous coronary intervention certification and maintenance of certification|Certification and Maintenance of Certification]] | |||
|- | |||
! | |||
:[[Percutaneous | |- bgcolor="PaleTurquoise" | ||
|- | ! | ||
! | :[[Percutaneous coronary intervention operator and institutional competency and volume|Operator and Institutional Competency and Volume]] | ||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " |
Latest revision as of 13:16, 21 June 2022
Percutaneous Coronary Intervention Guidelines Microchapters |
PCI Approaches: |
---|
CAD Revascularization: |
Pre-procedural Considerations: |
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
Quality and Performance Considerations: |
Percutaneous Coronary Intervention On the Web |
American Roentgen Ray Society Images of Percutaneous Coronary Intervention |
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Risk calculators and risk factors for Percutaneous Coronary Intervention |